Below are the financial statements of Sun Pharmaceutical Industries, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of INR | 2025 | 2024 |
|---|---|---|
| Revenue from operations | 525,784.4a | 484,968.5a |
| Other income | 19,650.4a | 13,541.9a |
| Total income | 545,434.8a | 498,510.4a |
| Expenses | — | — |
| Cost of materials consumed | -64,491a | -69,043.3a |
| Purchases of stock-in-trade | -41,479.5a | -34,661.5a |
| Changes in inventories of finished goods, stock-in-trade and work-in-progress | -1,503.1a | -2,921.3a |
| Employee benefits expense | -99,731.2a | -94,290.6a |
| Finance costs | -2,313.6a | -2,384.7a |
| Depreciation and amortisation expense | -25,753.9a | -25,566.4a |
| Other expenses | -167,718a | -154,181.8a |
| Net (gain) / loss on foreign currency transactions | -1,855.3a | -361.3a |
| Total expenses | -401,135a | -382,688.3a |
| Profit before exceptional items and tax | 144,299.8a | 115,822.1a |
| Exceptional items | 6,778.5a | 4,943.2a |
| Profit before tax | 137,521.3a | 110,878.9a |
| Tax expense / (credit) | — | — |
| Current tax | -33,200.5a | -19,893a |
| Deferred tax | -9,255a | -5,498.5a |
| Deferred tax - exceptional | -3,774.8a | 0a |
| Total tax expense | -27,720.3a | -14,394.5a |
| Profit for the year before share of profit / (loss) of associates and joint venture | 109,801a | 96,484.4a |
| Share of profit / (loss) of associates (net of tax) | -252.2a | -382.7a |
| Share of profit / (loss) of joint venture (net of tax) | 98.7a | -1.4a |
| Profit for the year before non-controlling interests | 109,647.5a | 96,100.3a |
| Non-controlling interests | 357.1a | 336.5a |
| Profit for the year attributable to owners of the parent company | 109,290.4a | 95,763.8a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.